Myriad Genetics Inc

MYGN NASDAQ Santé & Biotech États-Unis US62855J1043
3.85 $
0.92 %

Myriad Genetics Inc est une entreprise de diagnostic moléculaire qui développe et commercialise des tests prédictifs de cancer et d'autres maladies héréditaires.

Performance & Momentum

6 Months 50.58 %
1 Year 2.30 %
3 Years 83.16 %
5 Years 86.67 %

Similar stocks to Myriad Genetics Inc

Anantys Community

Be the first to share your analysis on Myriad Genetics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases